These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study. Lidegaard O BMJ; 1993 Apr; 306(6883):956-63. PubMed ID: 8490470 [TBL] [Abstract][Full Text] [Related]
43. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol. Akerlund M; Røde A; Westergaard J Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004 [TBL] [Abstract][Full Text] [Related]
44. Multicenter trial of two monophasic oral contraceptives containing 30 mcg ethinylestradiol and either desogestrel or gestodene in Thai women. Koetsawang S; Charoenvisal C; Banharnsupawat L; Singhakovin S; Kaewsuk O; Punnahitanont S Contraception; 1995 Apr; 51(4):225-9. PubMed ID: 7796587 [TBL] [Abstract][Full Text] [Related]
45. Results of oral contraceptive epidemiologic studies regarding neoplastic and cardiovascular effects. Grimes DA Int J Fertil; 1989; 34 Suppl():27-33. PubMed ID: 2576254 [TBL] [Abstract][Full Text] [Related]
46. Clinical experience with a modern low-dose oral contraceptive in almost 100,000 users. Brill K; Norpoth T; Schnitker J; Albring M Contraception; 1991 Feb; 43(2):101-10. PubMed ID: 2040166 [TBL] [Abstract][Full Text] [Related]
47. Oral contraceptives and neoplasia of the uterine corpus. Schlesselman JJ Contraception; 1991 Jun; 43(6):557-79. PubMed ID: 1868733 [TBL] [Abstract][Full Text] [Related]
48. [Influence of progestins on adverse effects of oral contraceptives]. Wynn V Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210 [TBL] [Abstract][Full Text] [Related]
49. Rebuilding confidence in oral contraceptives: a new imperative in family planning. Spitzer WO Br J Clin Pharmacol; 1996 May; 41(5):359-63. PubMed ID: 8735675 [TBL] [Abstract][Full Text] [Related]
50. Safety implications of transferring the oral contraceptive from prescription-only to over-the-counter status. Potts M; Denny C Drug Saf; 1995 Dec; 13(6):333-7. PubMed ID: 8652077 [TBL] [Abstract][Full Text] [Related]
51. The 1995 pill scare revisited: anatomy of a non-epidemic. Spitzer WO Hum Reprod; 1997 Nov; 12(11):2347-57. PubMed ID: 9436662 [TBL] [Abstract][Full Text] [Related]
52. Contraception in older woman. Volpe A; Silferi M; Genazzani AD; Genazzani AR Contraception; 1993 Mar; 47(3):229-39. PubMed ID: 8462314 [TBL] [Abstract][Full Text] [Related]
54. Pulsatile luteinizing hormone patterns in long term oral contraceptive users. Hemrika DJ; Slaats EH; Kennedy JC; de Vries Robles-Korsen TJ; Schoemaker J J Clin Endocrinol Metab; 1993 Aug; 77(2):420-6. PubMed ID: 8345046 [TBL] [Abstract][Full Text] [Related]
55. [Contraception without risk of breast disease: epidemiologic and physiopathologic arguments]. Le Coutour X NPN Med; 1985 Apr; 5(88):471-6. PubMed ID: 12315304 [TBL] [Abstract][Full Text] [Related]
60. Oral contraceptives and myocardial infarction: results of the MICA case-control study. Dunn N; Thorogood M; Faragher B; de Caestecker L; MacDonald TM; McCollum C; Thomas S; Mann R BMJ; 1999 Jun; 318(7198):1579-83. PubMed ID: 10364115 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]